home / stock / mreo / mreo news

MREO News and Press, Mereo BioPharma Group From 09/17/19

Stock Information
Company Name: Mereo BioPharma Group
Stock Symbol: MREO
Market: NASDAQ
Website: mereobiopharma.com
Menu
MREO MREO Quote MREO Short MREO News MREO Articles MREO Message Board
Get MREO Alerts

News, Short Squeeze, Breakout and More Instantly...
MREO - Mereo BioPharma Announces Interim Financial Results for the Six Months Ended June 30, 2019 and Provides Corporate Update

12-Month Topline Results from Phase 2b ASTEROID Study with Setrusumab for Osteogenesis Imperfecta (OI) Expected in Q4 2019; Positive 6-Month Data to be Featured in Late-Breaking Oral Presentation at ASBMR 2019 Conference Call Today at 8:30 a.m. EDT / 1:30 p.m. BST LONDON and REDWOOD C...
MREO - Key events next week - healthcare

Noteworthy events during the week of September 15 - 21 for healthcare investors. More news on: CRISPR Therapeutics AG, Pluristem Therapeutics Inc., GlaxoSmithKline plc, Healthcare stocks news, , Read more ...

MREO - Mereo BioPharma to Announce Interim Financial Results for the Six Months Ended June 30, 2019 and Provide Corporate Update on September 17, 2019

LONDON and REDWOOD CITY, Calif., Sept. 10, 2019 (GLOBE NEWSWIRE) -- Mereo BioPharma Group plc (NASDAQ: MREO, AIM: MPH), “Mereo” or the “Company” or the “Group,” a clinical stage biopharmaceutical company focused on rare diseases, today announces tha...

MREO - AEO, CRK, LL and TOPS among midday movers

Gainers:  OpGen (NASDAQ: OPGN ) +79% . Marinus Pharmaceuticals (NASDAQ: MRNS ) +35% . Top Ships (NASDAQ: TOPS ) +25% . Natuzzi S.p.A. (NYSE: NTZ ) +23% . Mereo BioPharma Group (NASDAQ: MREO ) +23% . Ovid Therapeutics (NASDAQ: OVID ) +19% . Owens & Minor (NYSE: OMI ) +19% . ...
MREO - Mereo Bio up 20% ahead of setrusumab data presentation

Thinly traded nano cap Mereo BioPharma Group plc ( MREO +20.3% ) is up on average volume, a scant 21K shares, in response to its announcement that six-month interim data form the open-label arm of its Phase 2b clinical trial, ASTEROID , evaluating setrusumab (BPS-804) in patients with o...

MREO - Mereo BioPharma Announces Setrusumab 6-Month Phase 2b Data in Osteogenesis Imperfecta Selected for Late-Breaking Oral Presentation at the American Society for Bone and Mineral Research (ASBMR) 2019 Annual Meeting

LONDON and REDWOOD CITY, Calif., Sept. 04, 2019 (GLOBE NEWSWIRE) -- Mereo BioPharma Group plc (NASDAQ: MREO, AIM: MPH), “Mereo” or the “Company” or the “Group,” a clinical stage biopharmaceutical company focused on rare diseases, today announce...

MREO - Mereo BioPharma Appoints Richard Francis as Head of Pharmaceutical Development

LONDON and REDWOOD CITY, Calif., July 16, 2019 (GLOBE NEWSWIRE) -- Mereo BioPharma Group plc (NASDAQ: MREO, AIM: MPH), a clinical stage biopharmaceutical company focused on rare diseases, today announces the appointment of Richard Francis as Head of Pharmaceutical Development, effective Aug...
MREO - CIR, CPE and GLPG among midday movers

Gainers:  Capricor Therapeutics (NASDAQ: CAPR ) +148% . Carolina Trust BancShares (NASDAQ: CART ) +30% . SSLJ.com Limited (YGTY) +29% . Chicken Soup for the Soul Entertainment (NASDAQ: CSSE ) +22% . AVROBIO (NASDAQ: AVRO ) +22% . Mereo BioPharma Group (NASDAQ: MREO ) +21% . Amer...

MREO - Mereo Bio up 31% on accelerated pathway for navicixizumab

Thinly traded nano cap Mereo BioPharma Group plc ( MREO +31.1% ) is up on almost a 13x surge in volume, albeit on turnover of only 261K shares, in response to its announcement that the FDA is on board with a potential accelerated approval pathway for bispecific antibody navicixizumab for...

MREO - Mereo BioPharma Announces Successful Type B Meeting with U.S. FDA and Outlines Accelerated Approval Pathway for Navicixizumab in Advanced Ovarian Cancer

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION AS DEFINED UNDER THE MARKET ABUSE REGULATION (EU) NO. 596/2014. UPON PUBLICATION OF THIS ANNOUNCEMENT THIS INFORMATION IS NOW CONSIDERED IN THE PUBLIC DOMAIN LONDON and REDWOOD CITY, Calif., July 15, 2019 (GLOBE NEWSWIRE) -- Mereo BioPharma...
Previous 10 Next 10